Market Research Logo

Competent Cells Market by Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) - Global Forecast to 2022

Competent Cells Market by Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) - Global Forecast to 2022

The global competent cells market is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, at a CAGR of 10.2%. Advancements in molecular cloning research due to the emergence of new technologies and the growing commercial demand for molecular cloned products and recombinant proteins are some the key factors driving the growth of this market. On the other hand, increasing market consolidation creating strong entry barriers and high cost of competent cells kits are restraining the growth of this market.

The electrocompetent cells segment is expected to register the highest CAGR during the forecast period
The competent cells market is classified on the basis of type into chemically competent cells and electrocompetent cells. Electrocompetent cells are expected to grow at the highest CAGR during the forecast period. Electrocompetent cells offer high transformation efficiencies, making them suitable for many molecular biology applications such as the generation of cDNA libraries or constructing gene banks.

Increasing intensity of research and technological advancements drives growth of the other applications segment
Based on application, the global competent cells market is broadly segmented into cloning, protein expression, and other applications. The other applications segment is expected to register the highest CAGR during the forecast period. This segment comprises of mutagenesis, single-stranded DNA production, lentiviral vector production, and large plasmid transformation. The growth in this segment is primarily attributed to increasing intensity of research and technological advancements.

Pharmaceutical & biotechnology companies segment is expected to witness the highest growth
The competent cells market is classified on the basis of end users into academic research institutes, contract research organizations (CROs), and pharmaceutical & biotechnology companies. Pharmaceutical & biotechnology companies are expected to grow at the highest CAGR during the forecast period. This is primarily due to the rising investments in research for developing genomics and proteomics-based products.

North America to account for the largest share of the market
Geographically, the competent cells market is dominated by North America, followed by Europe. The North American region is estimated to account for the largest share in 2017, and the trend is expected to continue during the forecast period. The growth in this market can be attributed to the presence of major key players in the region, technological advancements, growth in the biotechnology and pharmaceutical industries, and increasing inclination towards research based on genomics and proteomics.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type - Tier 1 – 25 %, Tier 2 – 35% and Tier 3 – 40%
• By Designation – C-level – 35%, Director-level – 25%, Others – 40%
• By Region – North America - 43%, Europe – 19%, APAC – 29%, RoW – 9%

Key players operating in the competent cells market include Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), GenScript Biotech Corporation (China), Agilent Technologies, Inc. (U.S.), Takara Bio, Inc. (Japan), Promega Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), QIAGEN N.V. (Netherlands), and New England Biolabs, Inc. (U.S.).

Study Coverage:
The report analyses the competent cells market by type, application, end user, and region. Apart from comprehensive geographic and product analysis and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the report profiles companies with product portfolios, developments, and strategies adopted by key players to maintain and increase their shares in the market. The above-mentioned market research data, market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions to be successful in the market.

Benefits of Buying this Report:
This report will enable both established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the five strategies mentioned below to strengthen their market shares.

The report provides insights on the following strategies:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the competent cells market. The report analyzes the competent cells market by type, application, and end user
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the competent cells market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various competent cell products across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the competent cells market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • MARKET SIZE ESTIMATION
    • DATA TRIANGULATION
    • MARKET SHARE ESTIMATION
      • KEY DATA FROM SECONDARY SOURCES
      • KEY DATA FROM PRIMARY SOURCES
      • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • COMPETENT CELLS: MARKET OVERVIEW
    • COMPETENT CELLS MARKET, BY CLONING APPLICATION (2017)
    • GEOGRAPHICAL SNAPSHOT OF THE COMPETENT CELLS MARKET
    • COMPETENT CELLS MARKET, BY APPLICATION, 2017 VS. 2022
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • COMPETENT CELLS MARKET, BY TYPE
    • INTRODUCTION
      • Table COMPETENT CELLS MARKET, BY TYPE, 2015-2022 (USD MILLION)
    • CHEMICALLY COMPETENT CELLS
      • Table CHEMICALLY COMPETENT CELLS MARKET, BY REGION, 2015-2022 (USD MILLION)
    • ELECTROCOMPETENT CELLS
      • Table ELECTROCOMPETENT CELLS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • COMPETENT CELLS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
    • CLONING
      • Table COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
      • Table COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • SUBCLONING & ROUTINE CLONING
        • Table COMPETENT CELLS MARKET FOR SUBCLONING & ROUTINE CLONING, BY REGION, 2015-2022 (USD MILLION)
      • PHAGE DISPLAY LIBRARY CONSTRUCTION
        • Table COMPETENT CELLS MARKET FOR PHAGE DISPLAY LIBRARY CONSTRUCTION, BY REGION, 2015-2022 (USD MILLION)
      • TOXIC/UNSTABLE DNA CLONING
        • Table COMPETENT CELLS MARKET FOR TOXIC/UNSTABLE DNA CLONING, BY REGION, 2015-2022 (USD MILLION)
      • HIGH-THROUGHPUT CLONING
        • Table COMPETENT CELLS MARKET FOR HIGH-THROUGHPUT CLONING, BY REGION, 2015-2022 (USD MILLION)
    • PROTEIN EXPRESSION
      • Table COMPETENT CELLS MARKET FOR PROTEIN EXPRESSION APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
    • OTHER APPLICATIONS
      • Table COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
      • Table COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • MUTAGENESIS
        • Table COMPETENT CELLS MARKET FOR MUTAGENESIS, BY REGION, 2015-2022 (USD MILLION)
      • LARGE PLASMID TRANSFORMATION
        • Table COMPETENT CELLS MARKET FOR LARGE PLASMID TRANSFORMATION, BY REGION, 2015-2022 (USD MILLION)
      • SINGLE-STRANDED DNA PRODUCTION
        • Table COMPETENT CELLS MARKET FOR SINGLE-STRANDED DNA PRODUCTION, BY REGION, 2015-2022 (USD MILLION)
      • LENTIVIRAL VECTOR PRODUCTION
        • Table COMPETENT CELLS MARKET FOR LENTIVIRAL VECTOR PRODUCTION, BY REGION, 2015-2022 (USD MILLION)
  • COMPETENT CELLS MARKET, BY END USER
    • INTRODUCTION
      • Table COMPETENT CELLS MARKET, BY END USER, 2015-2022 (USD MILLION)
    • ACADEMIC RESEARCH INSTITUTES
      • Table U.S. R&D PERFORMANCE, 2015
      • Table COMPETENT CELLS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
      • Table COMPETENT CELLS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2015-2022 (USD MILLION)
    • CONTRACT RESEARCH ORGANIZATIONS
      • Table COMPETENT CELLS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2015-2022 (USD MILLION)
  • COMPETENT CELLS MARKET, BY REGION
    • INTRODUCTION
      • Table COMPETENT CELLS MARKET, BY REGION, 2015-2022 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: COMPETENT CELLS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: COMPETENT CELLS MARKET, BY TYPE, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: COMPETENT CELLS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: COMPETENT CELLS MARKET, BY END USER, 2015-2022 (USD MILLION)
      • U.S.
        • Table U.S.: COMPETENT CELLS MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table U.S.: COMPETENT CELLS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table U.S.: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table U.S.: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table U.S.: COMPETENT CELLS MARKET, BY END USER, 2015-2022 (USD MILLION)
      • CANADA
        • Table CANADA: COMPETENT CELLS MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table CANADA: COMPETENT CELLS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table CANADA: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table CANADA: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table CANADA: COMPETENT CELLS MARKET, BY END USER, 2015-2022 (USD MILLION)
    • EUROPE
      • Table EUROPE: COMPETENT CELLS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table EUROPE: COMPETENT CELLS MARKET, BY TYPE, 2015-2022 (USD MILLION)
      • Table EUROPE: COMPETENT CELLS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
      • Table EUROPE: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • Table EUROPE: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • Table EUROPE: COMPETENT CELLS MARKET, BY END USER, 2015-2022 (USD MILLION)
      • GERMANY
        • Table GERMANY: COMPETENT CELLS MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table GERMANY: COMPETENT CELLS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table GERMANY: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table GERMANY: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table GERMANY: COMPETENT CELLS MARKET, BY END USER, 2015-2022 (USD MILLION)
      • U.K.
        • Table U.K.: COMPETENT CELLS MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table U.K.: COMPETENT CELLS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table U.K.: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table U.K.: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table U.K.: COMPETENT CELLS MARKET, BY END USER, 2015-2022 (USD MILLION)
      • FRANCE
        • Table FRANCE: COMPETENT CELLS MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table FRANCE: COMPETENT CELLS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table FRANCE: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table FRANCE: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table FRANCE: COMPETENT CELLS MARKET, BY END USER, 2015-2022 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: COMPETENT CELLS MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table ROE: COMPETENT CELLS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table ROE: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table ROE: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table ROE: COMPETENT CELLS MARKET, BY END USER, 2015-2022 (USD MILLION)
    • ASIA-PACIFIC
      • Table ASIA-PACIFIC: COMPETENT CELLS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table ASIA-PACIFIC: COMPETENT CELLS MARKET, BY TYPE, 2015-2022 (USD MILLION)
      • Table ASIA-PACIFIC: COMPETENT CELLS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
      • Table ASIA-PACIFIC: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • Table ASIA-PACIFIC: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • Table ASIA-PACIFIC: COMPETENT CELLS MARKET, BY END USER, 2015-2022 (USD MILLION)
      • JAPAN
        • Table JAPAN: COMPETENT CELLS MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table JAPAN: COMPETENT CELLS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table JAPAN: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table JAPAN: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table JAPAN: COMPETENT CELLS MARKET, BY END USER, 2015-2022 (USD MILLION)
      • AUSTRALIA
        • Table AUSTRALIA: COMPETENT CELLS MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table AUSTRALIA: COMPETENT CELLS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table AUSTRALIA: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table AUSTRALIA: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table AUSTRALIA: COMPETENT CELLS MARKET, BY END USER, 2015-2022 (USD MILLION)
      • CHINA
        • Table CHINA: COMPETENT CELLS MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table CHINA: COMPETENT CELLS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table CHINA: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table CHINA: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table CHINA: COMPETENT CELLS MARKET, BY END USER, 2015-2022 (USD MILLION)
      • INDIA
        • Table INDIA: COMPETENT CELLS MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table INDIA: COMPETENT CELLS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table INDIA: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table INDIA: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table INDIA: COMPETENT CELLS MARKET, BY END USER, 2015-2022 (USD MILLION)
      • REST OF APAC
        • Table REST OF APAC: COMPETENT CELLS MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table REST OF APAC: COMPETENT CELLS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table REST OF APAC: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table REST OF APAC: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table REST OF APAC: COMPETENT CELLS MARKET, BY END USER, 2015-2022 (USD MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: COMPETENT CELLS MARKET, BY TYPE, 2015-2022 (USD MILLION)
      • Table ROW: COMPETENT CELLS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
      • Table ROW: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • Table ROW: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • Table ROW: COMPETENT CELLS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • INTRODUCTION
    • MARKET SHARE ANALYSIS
    • COMPETITIVE LEADERSHIP MAPPING
      • VISIONARY LEADERS
      • INNOVATORS
      • DYNAMIC DIFFERENTIATORS
      • EMERGING COMPANIES
    • COMPETITIVE BENCHMARKING
      • BUSINESS STRATEGY EXCELLENCE (FOR 25 PLAYERS)
      • STRENGTH OF PRODUCT PORTFOLIO (FOR 25 PLAYERS)
  • COMPANY PROFILES
    • THERMO FISHER SCIENTIFIC INC.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS (2014-2017)
    • MERCK KGAA
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS (2014-2017)
    • PROMEGA CORPORATION
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS (2014-2017)
    • TAKARA BIO INC.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS (2014-2017)
    • NEW ENGLAND BIOLABS INC.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS (2014-2017)
    • BIO-RAD LABORATORIES, INC.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
    • TRANSGEN BIOTECH, INC.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
    • AGILENT TECHNOLOGIES, INC.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS (2014-2017)
    • ILLUMINA, INC.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS (2014-2017)
    • ZYMO RESEARCH
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
    • QIAGEN N.V.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
    • GENSCRIPT BIOTECH CORPORATION
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
    • ORIGENE TECHNOLOGIES, INC.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
  • APPENDIX
    • INDUSTRY INSIGHTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report